ADVERTISEMENT

 

Press Releases

 

14

Jan

2022

Polypharmacy, certain medication classes seem to worsen COVID-19 outcomes

Pharmacists are well aware that polypharmacy is a major issue among patients, especially older adults. Recent studies have estimated that approximately 36% of older adults take at least 5 prescription medications, and 67% take 5 or more medications or supplements, including OTCs.

Comments (0)
Number of views (28991)
Article rating: 4.4

11

Jan

2022

ISMP issues warning about possible safety issues with newly authorized antiviral

To encourage the appropriate use of Pfizer’s COVID-19 antiviral drug nirmatrelvir/ritonavir (Paxlovid), the Institute for Safe Medication Practices (ISMP) released an alert for dispensing pharmacists.

Comments (0)
Number of views (29232)
Article rating: No rating

11

Jan

2022

Many patients not receiving statins after lower-extremity revascularization

Author: Anonym

A new study in JAMA Network Open analyzed data from more than 125,000 patients who received lower-extremity revascularization between 2014 and 2019.

Comments (0)
Number of views (27340)
Article rating: No rating

10

Jan

2022

New HIV PrEP guidelines call for clinicians to talk with patients about prevention meds

CDC now advises all clinicians to talk to their patients who are sexually active, including adolescents, about HIV preexposure prophylaxis (PrEP) at least once and to prescribe the prevention medication to anyone who requests them.

Comments (0)
Number of views (36781)
Article rating: No rating

17

Dec

2021

Study links statins with more aggressive diabetes progression

Author: Anonym

Patients with diabetes who used statins experienced less control of their diabetes than patients who did not take statins, suggests a new retrospective study published in JAMA Internal Medicine.

Comments (0)
Number of views (49012)
Article rating: 4.2
RSS
First4344454648505152Last
Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT